Latest Regulatory Approval News

EBR Systems accelerated its U.S. commercial rollout of the WiSE CRT System in Q1 2026 with implant volumes more than doubling and revenue hitting US$2.4 million. The company also secured a key regulatory milestone in Australia with TGA Priority Review, yet losses deepened and cash burn intensified, raising fresh questions about its funding runway.

Energy Transition Minerals has secured a non-binding MOU with Traxys Europe for the potential exclusive offtake of tin, tantalum, and niobium concentrates from its Penouta mine, positioning the project as a strategic Western source of critical minerals.

Bindi Metals has kicked off its first diamond drilling campaign at the Ravni Gold Project, targeting a promising 2km mineralised corridor with high-grade gold results and strong geophysical anomalies.

Acrux Limited has raised $1.6 million through a discounted share placement, attracting strong demand and offering attaching options to investors. The funds will support Phase III trials for female testosterone and a co-development deal with an international partner.

Ainsworth Game Technology has confirmed Ryan Comstock as CEO after six months as acting chief, tying his pay to company performance through incentive plans.

Aguia Resources has addressed all regulatory queries for its Tres Estradas phosphate mine operating licence, with final approval expected soon. The project remains on track for mid-May operational readiness, while its Pampafos fertiliser offers a significant cost edge amid supply shortages in Southern Brazil.

Atlantic Lithium has consented to Elevra's transfer of its 22.5% interest in the Ewoyaa Lithium Project to Zhejiang Huayou Cobalt, enabling Huayou to assume sole funding responsibilities and potentially accelerating project development.

Larvotto Resources has identified a significant high-grade gold-antimony-tungsten mineralised system at Curry’s Block, with diamond drilling approved to test extensions. Tungsten’s critical mineral status and record prices add strategic weight to the project’s near-mine growth potential.

EMVision is broadening its emu™ Pivotal Trial to include acute ischaemia detection, aiming to accelerate FDA clearance and enhance the brain scanner's clinical impact. Recruitment has passed 125 patients across US and Australian sites, with full enrolment expected by early 2027.

Bioxyne expands its LATAM footprint by securing the first international medicinal cannabis flower supply agreement in Costa Rica, with initial shipments valued over $500,000 planned before June 2026.

Navigator Global Investments (ASX: NGI) has kicked off a fully underwritten entitlement offer to raise A$145 million, supporting its US$195 million acquisition of a portfolio of alternative asset manager stakes from Stable Asset Management.

Elevra Lithium has struck a US$71 million deal to offload its Ghanaian Ewoyaa Project interest to Zhejiang Huayou Cobalt, pivoting its strategy firmly towards North American assets while shedding funding obligations tied to Ewoyaa.